Clinical trials
Phase 3 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6,760 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 45 |
| 2001 | 73 |
| 2002 | 85 |
| 2003 | 122 |
| 2004 | 161 |
| 2005 | 205 |
| 2006 | 256 |
| 2007 | 237 |
| 2008 | 287 |
| 2009 | 265 |
| 2010 | 276 |
| 2011 | 297 |
| 2012 | 288 |
| 2013 | 280 |
| 2014 | 265 |
| 2015 | 324 |
| 2016 | 255 |
| 2017 | 283 |
| 2018 | 319 |
| 2019 | 315 |
| 2020 | 283 |
| 2021 | 328 |
| 2022 | 273 |
| 2023 | 289 |
| 2024 | 285 |
| 2025 | 304 |
| 2026 | 221 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4,054 |
| Terminated | 829 |
| Recruiting | 743 |
| Active, not recruiting | 730 |
| Unknown status | 249 |
| Not yet recruiting | 86 |
| Withdrawn | 31 |
| Enrolling by invitation | 29 |
| Suspended | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 389 |
| Novartis Pharmaceuticals | 297 |
| Hoffmann-La Roche | 295 |
| AstraZeneca | 239 |
| Sanofi | 187 |
| Pfizer | 162 |
| Eli Lilly and Company | 159 |
| Bristol-Myers Squibb | 154 |
| GlaxoSmithKline | 148 |
| Merck Sharp & Dohme LLC | 130 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 226 |
| Carcinoma, Non-Small-Cell Lung | 209 |
| Neoplasms | 150 |
| Diabetes Mellitus, Type 2 | 137 |
| Neoplasm Metastasis | 122 |
| Prostatic Neoplasms | 121 |
| Multiple Myeloma | 102 |
| HIV Infections | 85 |
| Colorectal Neoplasms | 84 |
| Recurrence | 84 |
Trials
Showing 1 to 25 of 6,760. Each trial links to its page on Pharma Observatory.
6,660 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.